EPHB3 and colorectal neoplasm: In EphB3−/−; ApcMin/+ mice, they documented 30% more colorectal tumors, a two-fold increase in tumor size >5 mm in diameter, and a three-fold increase in the percentage of invasive disease in comparison with EphB3+/−ApcMin/+.